CD79B

CD79B

CD79B 분자 정보

Molecule Name
B-cell antigen receptor complex-associated protein beta chain
분자 별명
CD79b,B29,IGB,Ig-beta
Drug Development Progress
임상 약물 수9
시판 약물 수1
최고 연구 개발 단계Approved
표적 별명
B-Cell Antigen Receptor Complex-Associated Protein Beta Chain,B29,Immunoglobulin-associated B29 protein,Ig-beta,B-cell-specific glycoprotein B29,CD79B,CD79b Molecule,CD79b Molecule, Immunoglobulin-Associated Beta,IGB,CD79B Antigen (Immunoglobulin-Associated Beta),CD79b Antigen,AGM6
분자 배경
B-cell antigen receptor complex-associated protein beta chain (CD79b) is also known as B-cell-specific glycoprotein B29, Ig-beta,Immunoglobulin-associated B29 protein, B29 and IGB, which is a single-pass type I membrane protein containing one Ig-like V-type ( immunoglobulin-like ) domain and one ITAM domain.CD79b is required in cooperation with CD79A for initiation of the signal transduction cascade activated by the B-cell antigen receptor complex (BCR).CD79b can enhance phosphorylation of CD79A, possibly by recruiting kinases which phosphorylate CD79A or by recruiting proteins which bind to CD79A and protect it from dephosphorylation. Defects in CD79b are the cause of agammaglobulinemia type 6 (AGM6) that is a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development.

CD79B 제품 목록

Species
  • Human(5)
  • Mouse(3)
  • Cynomolgus(2)
Tag
  • His Tag(5)
  • His Tag & Avi Tag(3)
  • Fc Tag(2)
Host
  • HEK293(10)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(3)
  • PE Labeled(1)
Grade
  • RUO(10)
Low Endotoxin
  • Yes(4)
  • No(6)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
CD79B
Human CD79B Protein, His Tag
Human
HEK293
HPLCSDS-PAGE
SPR

$1190.00

250ug
CD79B
PE-Labeled Human CD79B Protein, His Tag (Site-specific conjugation)
Human
HEK293

$360.00

25tests
CD79B
HOTAvitag
CDB-H82E3
Biotinylated Human CD79B Protein, His,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISATR-FRET

$415.00

25ug
CD79B
Human CD79B Protein, Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$315.00

100ug
CD79B
Human CD79B Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$415.00

100ug
CD79B
Cynomolgus CD79B Protein, His Tag, low endotoxin (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$415.00

100ug
CD79B
Avitag
CDB-C82E5
Biotinylated Cynomolgus CD79B Protein, His,Avitag™
Cynomolgus
HEK293
SDS-PAGE

$360.00

25ug
CD79B
Mouse CD79B Protein, Fc Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$360.00

100ug
CD79B
Mouse CD79B Protein, His Tag, low endotoxin (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$395.00

100ug
CD79B
Avitag
CDB-M82E3
Biotinylated Mouse CD79B Protein, His,Avitag™ (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$360.00

25ug
You Have Viewed 1-10 Of 10 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
SHR-A1912SHR-A1912Phase 3 ClinicalShanghai Hengrui Pharmaceutical Co Ltd
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse
상세
CD19/79b Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR CD19/79bPhase 2 ClinicalShenzhen Geno-Immune Medical Institute
Leukemia, B-Cell; Lymphoma, B-Cell
상세
TolDCB29Phase 2 ClinicalUmc Utrecht
Arthritis, Rheumatoid
상세
JNJ-95566692JNJ-95566692Phase 1 ClinicalJanssen Research & Development Llc
Lymphoma, Non-Hodgkin
상세
LTZ-301LTZ-301Phase 1 ClinicalLTZ Therapeutics Inc
Autoimmune Diseases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin
상세
CD79b-19 CAR T Cells Therapy (Massachusetts General Hospital)Phase 1 ClinicalMassachusetts General Hospital
Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Primary mediastinal B cell lymphoma
상세
Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy(MD Anderson Cancer Center)JV-213Phase 1 ClinicalThe University Of Texas MD Anderson Cancer Center
Lymphoma; Lymphoma, B-Cell
상세
NBT-508Phase 1 ClinicalNewbio Therapeutics Inc
Lymphoma, B-Cell; Lymphoma, Non-Hodgkin
상세
CD79b CAR-T cell therapy (Yake Biotechnology)Phase 1 ClinicalShanghai YaKe Biotechnology Co Ltd, Zhejiang University
Leukemia, Biphenotypic, Acute; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Polatuzumab vedotinRO-5541077-000; FCU-2711; DCDS-4501A; RG-7596; RO-5541077ApprovedGenentech Inc, Seagen IncPolivy, 优罗华United StatesLymphoma, Large B-Cell, DiffuseGenentech Inc2019-06-10
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
상세
Customer Reviews